Dubousset Functional Test: an Investigation of Its Validity and Reliability in Individuals with Multiple Sclerosis

What this Trial Is About

Multiple sclerosis (MS) is an autoimmune disease that causes inflammation and damage in the central nervous system, affecting brain and spinal cord areas responsible for movement and balance. This study investigates the validity and reliability of the Dubousset Functional Test (DFT), a practical assessment designed to measure physical function and balance in people with MS. The DFT focuses on spinopelvic muscle function and includes a dual-task test to evaluate coordination, balance, attention, and thinking skills during activity, which may provide useful insights for treatment. Participants will undergo the DFT, which consists of four parts: standing up and walking 5 meters forward and backward, climbing and descending steps, sitting and standing from the floor with assistance if needed, and walking while performing a memory task. Additional assessments include the Timed Up and Go (TUG) test, dual-task TUG, Tinetti Performance Oriented Mobility Assessment (POMA), Berg Balance Scale (BBS), Functional Reach Test, and 3-meter backward walking test. The DFT will be administered twice, one week apart, by the same physiotherapist to assess reliability. During the study, participants' demographic and health details will be recorded along with neurological disability scores using the Expanded Disability Status Scale (EDSS). Tests will measure balance, walking ability, and functional performance. Rest breaks will be given to minimize fatigue, and no treatments will be given between the two test sessions. Researchers will analyze the data to understand the DFT's effectiveness in assessing functional capacity and balance in individuals with MS. The study is expected to continue until May 2025.

Dubousset Functional Test: an Investigation of Its Validity and Reliability in Individuals with Multiple Sclerosis